Trial Profile
A Multicenter, Randomized, Double-Blind, Parallel Group Study, Comparing The Efficacy And Tolerability Of Ziprasidone (Zeldox, Geodon) vs. Olanzapine (Zyprexa) In The Treatment And Maintenance Of Response In Patients With Acute Mania
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 30 Sep 2021
Price :
$35
*
At a glance
- Drugs Ziprasidone (Primary) ; Olanzapine
- Indications Bipolar I disorders; Mania
- Focus Therapeutic Use
- Acronyms ZOOM
- Sponsors Pfizer
- 30 Sep 2021 This trial has been completed in France (End Date: 10 Jan 2007), according to European Clinical Trials Database record.
- 02 Sep 2021 This trial has been completed in Spain, according to European Clinical Trials Database.
- 12 Mar 2009 Actual patient number changed from 28 to 29 as reported by ClinicalTrials.gov.